下肢骨折患者医疗费用在过去10年不成比例增长:基于医疗支出面板调查的总支出与自付费用分析
本研究基于2010至2021年美国医疗支出面板调查(MEPS),将3016例下肢骨折患者与15080例无骨折对照进行倾向性评分匹配,比较总支出和自付费用。结果显示下肢骨折患者总支出为20230美元、自付费用为1634美元,均高于对照组;过去十年下肢骨折患者总支出增长101.2%,远高于对照组的51.4%,但自付费用增长两组差异未达统计学显著。
要点
- 下肢骨折患者总支出20230美元,高于对照组的10678美元(p<0.001)。
- 下肢骨折患者自付费用1634美元,高于对照组的1089美元(p<0.001)。
- 2010至2021年下肢骨折患者总支出增长101.2%,对照组增长51.4%(p<0.001)。
核心结论
- 下肢骨折与较高的总支出和自付费用相关,且过去十年其增长幅度与一般医疗费用不成比例。
- 住院后护理是总支出和自付费用的最大驱动因素。
- 由于MEPS数据库的固有局限性,经济负担对支付方、个人及其医疗决策的影响尚不清楚,需要进一步研究。
研究设计与样本
- 基于医疗支出面板调查(MEPS)的倾向性评分匹配分析,纳入2010至2021年美国非机构化人群中3016例下肢骨折患者,与15080例无下肢骨折的MEPS参与者进行匹配。
- 下肢骨折患者以40至64岁(43.2%)、女性(66.0%)、白人(78.8%)为主。
- 比较两组的总支出和自付费用,采用多变量回归分析识别与费用相关的因素,结局按2022年消费者价格指数调整。
主要发现
- 下肢骨折组总支出为20230美元(95%CI,18916至21543),对照组为10678美元(95%CI,10302至11053),p<0.001。
- 下肢骨折组自付费用为1634美元(95%CI,1516至1753),对照组为1089美元(95%CI,1050至1128),p<0.001。
- 2010至2021年间,下肢骨折组总支出增长101.2%,对照组增长51.4%(p<0.001);自付费用两组分别增长61.1%和44.5%(p=0.17)。
- 在下肢骨折组中,总支出主要由住院护理、诊室就诊和处方费用驱动;自付费用主要由诊室就诊、处方费用和「其他」来源驱动。
- 股骨骨折、住院和某些合并症与较高的总支出相关;住院、无保险状态和较高收入水平与自付费用增加相关,而非裔美国人或西班牙裔背景及较低教育水平与较低自付费用相关。
局限性
- 由于MEPS数据库的固有局限性,经济负担对支付方、个人及其医疗决策的影响尚不清楚,需要进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Increasing U.S. health-care costs raise concerns regarding the sustainability of the U.S. health-care system, with the potential for negative effects on the mental and physical health of patients. Orthopaedic injuries often impose considerable financial burdens on patients and hospitals, but the trends in, and drivers of, costs remain unclear. This study evaluated the total expenditure and out-of-pocket (OOP) costs of patients with a lower-extremity (LE) fracture in the non-institutionalized U.S. population from 2010 to 2021. METHODS: A total of 3,016 participants with an LE fracture from the Medical Expenditure Panel Survey (MEPS) were propensity score matched with 15,080 MEPS participants with no LE fracture. Patients with an LE fracture were predominantly between 40 and 64 years old (43.2%), female (66.0%), and White (78.8%). Total expenditure and OOP costs were compared between the groups. A multivariable regression analysis was performed to identify factors that were associated with costs. Outcomes were adjusted on the basis of the 2022 Consumer Price Index. RESULTS: Patients with an LE fracture had greater total expenses than the control group ($20,230 [95% confidence interval (CI), $18,916 to $21,543] versus $10,678 [95% CI, $10,302 to $11,053]; p < 0.001) as well as greater OOP costs ($1,634 [95% CI, $1,516 to $1,753] versus $1,089 [95% CI, $1,050 to $1,128]; p < 0.001). Between 2010 and 2021, total expenses increased more for patients with an LE fracture than for the control group (101.2% versus 51.4%; p < 0.001), whereas OOP costs increased to a lesser degree in both groups (61.1% versus 44.5%; p = 0.17). In the LE fracture group, total expenditure was driven by inpatient care, office-based visits, and prescription costs, whereas OOP costs were driven by office-based visits, prescription costs, and "other" sources. Femoral fracture, hospitalization, and certain comorbidities were associated with higher total expenses. Hospitalization, uninsured status, and a higher income level were associated with increased OOP costs, whereas African American or Hispanic background and a lower educational level were associated with lower OOP costs. CONCLUSIONS: An LE fracture was associated with considerable total expenditure and OOP costs, which increased disproportionately compared with general health-care costs over the past decade. Post-hospitalization care was the biggest driver of both total expenses and OOP costs. Due to limitations inherent to the MEPS database, the impact of financial burden on not only payers but also individuals and their medical decision-making remains unclear and requires further investigation. LEVEL OF EVIDENCE: Economic Level III . See Instructions for Authors for a complete description of levels of evidence.
引用
- Raats JH, Chang Y, Brameier DT, et al. Health-Care Costs for Patients with a Lower-Extremity Fracture Have Increased Disproportionately Over the Past 10 Years: A Medical Expenditure Panel Survey Analysis of Total Expenditure and Out-of-Pocket Costs. J Bone Joint Surg Am. 2025. PMID: 39970239. doi:10.2106/JBJS.24.00544
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。